Mar 28 |
Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
|
Mar 28 |
Earnings Scheduled For March 28, 2024
|
Mar 15 |
Helius Medical Technologies, Inc. to Release Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024
|
Mar 12 |
Helius Medical Technologies, Inc. Initiates Open-Label Study for Registrational Program in Stroke
|
Mar 7 |
Helius Medical Technologies, Inc. to Present at the 36th Annual ROTH Conference
|
Mar 4 |
Helius Medical stock rallies 19% on CMS code assignments
|
Mar 4 |
Helius Medical Technologies, Inc. Secures HCPCS Codes for Portable Neuromodulation Stimulator (PoNS®) Mouthpiece and Controller
|
Feb 6 |
Helius Medical shares rally 25% on FDA meeting
|
Feb 6 |
Helius Medical Technologies, Inc. Announces Alignment with FDA on Registrational Program for Treatment of Stroke Patients
|
Feb 5 |
Helius Booth and Special Event at APTA Combined Sections Meeting Will Highlight Physical Therapists’ Ability to Customize PoNS Therapy® to Improve Gait in People with MS
|